Method for preventing and/or ameliorating inflammation

• US 20080172105A1
• Filed: 09/06/2007
• Published: 07/17/2008
• Est. Priority Date: 01/17/2007
• Status: Abandoned Application

• Current Assignee: WS FAR IR Medical Technology Co., Ltd.
• Original Assignee: WS FAR IR Medical Technology Co., Ltd.
• Inventors: Lee, Chyi-Ran, Lin, Chih-Ching
• Application Number:
  US11/896,879
• Publication Number:
  US 20080172105A1
• Time in Patent Office: Days
• US Class Current: 607/50
• CPC Class Codes: A61N 2005/066 far infrared
• CPC Class Codes: A61N 5/0613 Apparatus adapted for a specific treatment

Abstract

A method for preventing and/or ameliorating inflammation. The method comprises irradiating a biological subject with an electromagnetic wave from an emitter, wherein the electromagnetic wave has a wavelength of about 1.5 to 100 μm μm, and the biological subject can be a peripheral vascular disease patient. Additionally, the method of the invention can improve the access blood flow and unassisted patency of arteriovenous fistula in hemodialysis patients.

Claims

1. A method for preventing and/or ameliorating inflammation, comprising irradiating a biological subject with an electromagnetic wave from an emitter to inhibit inflammation in the biological subject, wherein the electromagnetic wave has a wavelength range of about 1.5 to 100 μ

m.

2. The method as claimed in claim 1, wherein the distance between the emitter and the surface of the biological subject is about 0.1 to 60 cm.

3. The method as claimed in claim 1, wherein the electromagnetic wave has a peak in a wavelength of about 5 to 8 μ

m.

4. The method as claimed in claim 1, wherein the surface temperature of the biological object is about 30°

C. to 45°

C.

5. The method as claimed in claim 1, wherein the power density of the emitter of the electromagnetic wave is lower than 1.3 W/cm².

6. The method as claimed in claim 1, wherein the irradiating time of the electromagnetic wave exceeds about 10 minutes per treatment session.

7. The method as claimed in claim 1, wherein the treatment frequency of the electromagnetic wave is at least once every two days.

8. The method as claimed in claim 1, wherein the inflammation is endothelial cell inflammation.

9. The method as claimed in claim 1, wherein the biological subject comprises a mammalian.

10. The method as claimed in claim 1, wherein the biological subject is a human.

11. The method as claimed in claim 1, wherein the biological subject is an inflammation-related cardiovascular disorders patient and/or peripheral vascular diseases patient.

12. The method as claimed in claim 11, wherein the inflammation-related cardiovascular disorders comprises vascular diseases, peripheral vascular diseases, coronary artery disease, vasculitis including arteritis, phlebitis and thrombophlebitis, stenosis, atherosclerosis, or thrombosis including venous thrombosis.

13. The method as claimed in claim 12, wherein the peripheral vascular diseases comprises peripheral artery occlusive diseases, diabetic arteriosclerosis obliterans, a arteriovenous fistula or graft dysfunction, varicosity, macroangiopathy and microangiopathy, cerebrovascular diseases, superficial thrombophlebitis, phlebitis, thromboangiitis obliterans (TAO or Buerger'"'"'s disease), rheumatoid vasculitis, or Raynaud'"'"'s syndrome.

14. A method for preventing and/or ameliorating peripheral vascular diseases caused by an inflammation-induced vascular stenosis, comprising irradiating a skin of a biological subject with an electromagnetic wave from an emitter to improve blood flow and patency in the biological subject, wherein the electromagnetic wave has a wavelength of about 1.5 to 100 μ

m, and the biological subject is a peripheral vascular disease patient.

15. The method as claimed in claim 14, wherein the distance between the emitter and the surface of the biological subject is about 0.1 to 60 cm.

16. The method as claimed in claim 14, wherein the electromagnetic wave has a peak in a wavelength of about 5 to 8 μ

m.

17. The method as claimed in claim 14, wherein the surface temperature of the biological object is about 30°

C. to 45°

C.

18. The method as claimed in claim 14, wherein the power density of the emitter of the electromagnetic wave is lower than 1.3 W/cm².

19. The method as claimed in claim 14, wherein the irradiating time of the electromagnetic wave exceeds 10 minutes per treatment session.

20. The method as claimed in claim 14, wherein treatment frequency of the electromagnetic wave radiation is at least once every two days.

21. The method as claimed in claim 14, wherein the inflammation is an endothelial cell inflammation.

22. The method as claimed in claim 14, wherein the peripheral vascular diseases comprises peripheral artery occlusive diseases, diabetic arteriosclerosis obliterans, a arteriovenous fistula or graft dysfunction, varicosity, macroangiopathy and microangiopathy, cerebrovascular diseases, superficial thrombophlebitis, phlebitis, thromboangiitis obliterans (TAO or Buerger'"'"'s disease), rheumatoid vasculitis, or Raynaud'"'"'s syndrome.